Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,220,489 papers from all fields of science
Search
Sign In
Create Free Account
Y 23023
Known as:
Y-23023
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
[Mechanism of analgesic action of Y-23023, a new non-steroidal anti-inflammatory drug].
H. Ochi
,
Y. Yasunaga
,
+4 authors
M. Terasawa
Nihon yakurigaku zasshi. Folia pharmacologica…
1995
Corpus ID: 39494585
The analgesic mechanism of Y-23023, a new non-steroidal anti-inflammatory drug, was investigated in the writhing response induced…
Expand
1995
1995
[Analgesic and anti-inflammatory effect of (+/-)-N,N- dimethylcarbamoylmethyl 2-[7-(2-methyl-5H-[1] benzopyrano [2,3-b] pyridyl)] propionate (Y-23023), a new non-steroidal anti-inflammatory drug].
Y. Iwahisa
,
Y. Yasunaga
,
H. Ochi
,
M. Matsuura
,
T. Imayoshi
,
M. Terasawa
Nihon yakurigaku zasshi. Folia pharmacologica…
1995
Corpus ID: 45863642
The analgesic and anti-inflammatory activities of Y-23023, a new nonsteroidal analgesic and anti-inflammatory compound, were…
Expand
1995
1995
(±)-N, N-Dimethylcarbamoylmethyl 2-[7-(2-methyl-5H-[1]benzopyrano[2,3-b]pyridyl)]propionate (Y-23023) ラットにおける12カ月反復経口投与毒性試験
豊吉 亨
,
小川 明彦
,
+6 authors
堀田 宏
1995
Corpus ID: 92861008
1994
1994
Pharmacokinetic behaviour in polymorphonuclear leucocytes of N,N‐dimethylcarbamoylmethyl α,2‐dimethyl‐5H‐[1]benzopyrano[2,3‐b]‐pyridine‐7‐acetate (Y‐23023), a new prodrug type of antiinflammatory…
I. Yamada
,
Y. Nagamatsu
,
T. Imayoshi
,
M. Shibata
,
A. Tsuji
The Journal of pharmacy and pharmacology
1994
Corpus ID: 21279609
Abstract— N,N‐Dimethylcarbamoylmethyl α,2‐dimethyl‐5H‐[1]‐benzopyrano[2,3‐b]pyridine‐7‐acetate (Y‐23023) is a prodrug developed…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE